United Therapeutics Corp. (UTHR)
| Sector: | Health Care |
| |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 859 |
| % of all portfolios: | 0% |
| |
| History |
Portfolio Manager |
Activity |
Share change |
% change to portfolio ▼ |
| Q1 2026 |
| ≡ |
Mairs & Power Funds |
Buy |
350 |
0.00 |
| Q3 2024 |
| ≡ |
Richard Pzena - Pzena Investment Management |
Sell 100.00% |
1,599 |
0.00 |
| Q2 2024 |
| ≡ |
Richard Pzena - Pzena Investment Management |
Reduce 23.75% |
498 |
0.00 |
| Q4 2021 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
4,361 |
0.01 |
| Q3 2021 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 47.79% |
3,992 |
0.01 |
| Q2 2021 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 11.17% |
839 |
0.00 |
| Q1 2021 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
7,514 |
0.01 |
| Q1 2020 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
14,781 |
0.02 |
| Q4 2019 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 15.82% |
2,019 |
0.00 |
| Q3 2019 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
12,762 |
0.01 |
| Q3 2017 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
18,720 |
0.03 |
| Q2 2017 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 3.70% |
720 |
0.00 |
| Q1 2017 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 25.83% |
6,770 |
0.01 |
| Q4 2016 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 1.16% |
300 |
0.00 |
| Q3 2016 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 3.00% |
800 |
0.00 |
| Q2 2016 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 27.62% |
5,780 |
0.01 |
| Q1 2016 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 98.01% |
10,360 |
0.02 |
| Q4 2015 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 9.65% |
930 |
0.00 |
| Q3 2015 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 155.70% |
5,870 |
0.01 |
| Q2 2015 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 16.22% |
730 |
0.00 |
| Q1 2015 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
4,500 |
0.01 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.